TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
3D Medicines, Inc. ( (HK:1244) ) has shared an announcement.
3D Medicines Inc. announced a change in its board of directors, with Mr. Zhu Pai retiring as a non-executive director to focus on other engagements. The board expressed gratitude for his contributions. Following his retirement, the company proposes appointing Mr. Zhu Jinqiao, who has extensive experience in investment and entrepreneurship consulting, as the new non-executive director. This transition may influence the company’s strategic direction, given Mr. Zhu Jinqiao’s notable background and achievements in the healthcare investment sector.
More about 3D Medicines, Inc.
3D Medicines Inc. is a company incorporated in the Cayman Islands, operating with its subsidiaries as a group. The company is listed on the Stock Exchange of Hong Kong Limited, but specific details about its industry, primary products, services, or market focus are not provided in the announcement.
Average Trading Volume: 277,741
Technical Sentiment Signal: Hold
Current Market Cap: HK$1.09B
Find detailed analytics on 1244 stock on TipRanks’ Stock Analysis page.